2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1437682895 M.B,B.S.
Verify on CMS →

AYESHA MEHFOOZ, M.B,B.S.

Endocrinology, Diabetes & Metabolism Physician in MINNEAPOLIS, Minnesota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
870
Medicare Part D claims · 166 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4268/100
▲ 8 pts above national avg 83.1 · [object Object]
What the federal data reveals: AYESHA MEHFOOZ, M.B,B.S. is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in MINNEAPOLIS, Minnesota with a Medicare Part D prescribing footprint of 870 claims across 166 beneficiaries — 46% brand-name prescribing . Their CMS MIPS Final Score of 91.4268/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What stands out: AYESHA MEHFOOZ, M.B,B.S. reported a CMS MIPS final score of 91.4268 out of 100, above the 83.1 national average, and filed 870 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

AYESHA MEHFOOZ, M.B,B.S. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

AYESHA MEHFOOZ, M.B,B.S. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 04/04/2017

NPI 1437682895

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

870 67% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

91.4268/100 8.326800000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Minnesota

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Minnesota providers

Minnesota providers

Endocrinology, Diabetes & Metabolism Physician share within Minnesota

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Minnesota

Medicare quality performance — MIPS

AYESHA MEHFOOZ, M.B,B.S.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
91.4268/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 91.4268/100 vs national avg 83.1

0%100%National avg83%91.4%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 91.4268/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AYESHA MEHFOOZ, M.B,B.S. is a Endocrinology, Diabetes & Metabolism Physician provider practicing in MINNEAPOLIS, Minnesota, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.B,B.S.. NPI: 1437682895. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AYESHA MEHFOOZ, M.B,B.S. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.B,B.S. credentials at 701 PARK AVE, MINNEAPOLIS, MN, 55415, with a listed phone of (612) 873-6963. NPI 1437682895 was issued on 04/04/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MEHFOOZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 870 prescription claims written by this provider, covering 166 Medicare beneficiaries and totaling roughly $358K in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4268/100 for the 2023 performance year (Quality 78.7821, Cost 62.8019), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

701 PARK AVE
MINNEAPOLIS, MN 55415

Provider Details

NPI 1437682895
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.B,B.S.
Gender Female
NPI Issued 04/04/2017

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.4268
Final Score
Avg: 83.1
78.7821
Quality
62.8019
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where AYESHA MEHFOOZ, M.B,B.S. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HENNEPIN HEALTHCARE SYSTEM INC
MINNEAPOLIS, MN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

AYESHA MEHFOOZ, M.B,B.S. — brand share 46.0%
Specialty average (est.)

46% brand-name claims vs 54% generic, on 870 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

870
Total Claims
$358K
Total Drug Cost
166
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,526
Total Day Supply
44,030
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$338K
Generic Drug Cost
$10K

Patient Demographics

Average Patient Age
65.5 years
Avg HCC Risk Score
1.88
Gender Split
55% female / 45% male
Age Distribution
<65: 63, 65-74: 75, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Alendronate Sodium
142
Levothyroxine Sodium
59
Metformin Hcl Er
Metformin Hcl
59
Ozempic
Semaglutide
48
Novolog Flexpen
Insulin Aspart
39
Humalog Kwikpen U-100
Insulin Lispro
30
Jardiance
Empagliflozin
29
Prednisone
23
Trulicity
Dulaglutide
23
Testosterone
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How AYESHA MEHFOOZ, M.B,B.S. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

AYESHA MEHFOOZ, M.B,B.S.'s 870 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Minnesota

Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as MEHFOOZ.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AYESHA MEHFOOZ, M.B,B.S.'s specialty?
AYESHA MEHFOOZ, M.B,B.S. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in MINNEAPOLIS, Minnesota. Credentials: M.B,B.S..
How much does AYESHA MEHFOOZ, M.B,B.S. prescribe under Medicare Part D?
In 2023, AYESHA MEHFOOZ, M.B,B.S. wrote 870 Medicare Part D claims totaling $358K in drug costs for 166 beneficiaries.
What is AYESHA MEHFOOZ, M.B,B.S.'s Medicare quality score?
AYESHA MEHFOOZ, M.B,B.S. has a CMS MIPS Final Score of 91.4268/100 (Quality: 78.7821, Cost: 62.8019). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AYESHA MEHFOOZ, M.B,B.S. located?
AYESHA MEHFOOZ, M.B,B.S. is located at 701 PARK AVE, MINNEAPOLIS, MN, 55415. Phone: (612) 873-6963.
What is AYESHA MEHFOOZ, M.B,B.S.'s NPI number?
AYESHA MEHFOOZ, M.B,B.S.'s National Provider Identifier (NPI) is 1437682895, issued on 04/04/2017.
Does AYESHA MEHFOOZ, M.B,B.S. prescribe more brand-name or generic drugs?
AYESHA MEHFOOZ, M.B,B.S.'s prescribing is 46% brand-name and 54% generic drugs by claim count, with $338K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does AYESHA MEHFOOZ, M.B,B.S. prescribe most often?
Based on 2023 Medicare Part D data, AYESHA MEHFOOZ, M.B,B.S.'s most frequently prescribed drugs include Alendronate Sodium, Levothyroxine Sodium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AYESHA MEHFOOZ, M.B,B.S. accept Medicare?
AYESHA MEHFOOZ, M.B,B.S. appears in CMS Medicare data with 870 Part D claims and 166 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AYESHA MEHFOOZ, M.B,B.S.'s credentials?
AYESHA MEHFOOZ, M.B,B.S.'s NPI is 1437682895 with credentials M.B,B.S.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology